Volume 2, Issue 1 (2006) | American Journal of ImmunologyVolume 2, Issue 1 (2006) | American Journal of Immunology
https://thescipub.com/aji/issue/184
Science PublicationsenScience Publications<![CDATA[Selective Lymphocyte Activation and Inhibition of <i>In Vitro</i> Tumor Cell Growth by Novel Morphinans]]>
https://thescipub.com/aji/ajisp.2006.1.7
American Journal of Immunology, Published online: 5 March 2005; doi:10.3844/ajisp.2006.1.7Opioids can suppress immune functions and increase susceptibility to developing cancer and infectious diseases. Recently, novel opioid compounds have been synthesized that lack immunosuppressive effec...]]>In Vitro Tumor Cell Growth by Novel Morphinans]]>Ricardo Gomez-FloresKimberly R. ViettiWilliam J. DunnReyes Tamez-GuerraRichard J. Weberdoi:10.3844/ajisp.2006.1.7American Journal of Immunology, Published online: 2005-03-05; | doi:10.3844/ajisp.2006.1.72005-03-05Science Publications10.3844/ajisp.2006.1.7https://thescipub.com/aji/ajisp.2006.1.7<![CDATA[Na,K-ATPase α Subunit-like Immunoreactive Proteins in Human Body Fluids]]>
https://thescipub.com/aji/ajisp.2006.8.11
American Journal of Immunology, Published online: 31 March 2006; doi:10.3844/ajisp.2006.8.11Na,K-ATPase was recently considered a target for breast cancer treatment since its potent inhibitors ouabain and related digitalis compounds that were reported circulating in body fluids before, were ...]]>Jeng-Hsiung F. Pengdoi:10.3844/ajisp.2006.8.11American Journal of Immunology, Published online: 2006-03-31; | doi:10.3844/ajisp.2006.8.112006-03-31Science Publications10.3844/ajisp.2006.8.11https://thescipub.com/aji/ajisp.2006.8.11<![CDATA[Introduction of Three Complementary Technologies into Clinical Medicine: Development of New Diagnostic and Prognostic Parameters]]>
https://thescipub.com/aji/ajisp.2006.12.18
American Journal of Immunology, Published online: 31 March 2006; doi:10.3844/ajisp.2006.12.18Molecular medicine leads us to understand some diseases at the molecular level. Examples are the analysis of immune complexes and receptor - anti receptor compounds used in clinical medicine. Structur...]]>Gernot P. TilzMarco WiltgenUlrike DemelChristian FaschingerHans SchmiedingerAlbin Hermetterdoi:10.3844/ajisp.2006.12.18American Journal of Immunology, Published online: 2006-03-31; | doi:10.3844/ajisp.2006.12.182006-03-31Science Publications10.3844/ajisp.2006.12.18https://thescipub.com/aji/ajisp.2006.12.18<![CDATA[Polymyositis Initiation Involving Amlodipine Besylate]]>
https://thescipub.com/aji/ajisp.2006.19.22
American Journal of Immunology, Published online: 31 March 2006; doi:10.3844/ajisp.2006.19.22Based on extensive blood pressure data and results from a scientific model of the analysis of the rate processes involved in polymyositis the evidence suggests that the polymyositis in a particular pa...]]>R. M. GoldingL. G.F. GilesE. M. Sokoyadoi:10.3844/ajisp.2006.19.22American Journal of Immunology, Published online: 2006-03-31; | doi:10.3844/ajisp.2006.19.222006-03-31Science Publications10.3844/ajisp.2006.19.22https://thescipub.com/aji/ajisp.2006.19.22<![CDATA[DFT Based Electrophilicity Index and QSAR study of Phenols as Anti Leukaemia Agent]]>
https://thescipub.com/aji/ajisp.2006.23.28
American Journal of Immunology, Published online: 31 March 2006; doi:10.3844/ajisp.2006.23.28Density Functional reactivity indices based QSAR study of 49 phenol derivatives is presented in this paper. Two different models to describe the anti leukaemia activity of phenols have been made. Firs...]]>Farhan A. PashaHemant K. SrivastavaYakoob BegPashupati P. singhdoi:10.3844/ajisp.2006.23.28American Journal of Immunology, Published online: 2006-03-31; | doi:10.3844/ajisp.2006.23.282006-03-31Science Publications10.3844/ajisp.2006.23.28https://thescipub.com/aji/ajisp.2006.23.28